Is Lexicon Pharmaceuticals Inc (LXRX) a Leader in the Biotechnology Industry?

Lexicon Pharmaceuticals Inc (LXRX) is near the top in its industry group according to InvestorsObserver. LXRX gets an overall rating of 61. That means it scores higher than 61 percent of stocks. Lexicon Pharmaceuticals Inc gets a 71 rank in the Biotechnology industry. Biotechnology is number 20 out of 148 industries.

LXRX has an Overall Score of 61. Find out what this means to you and get the rest of the rankings on LXRX!

See Full LXRX Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 61 would rank higher than 61 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Lexicon Pharmaceuticals Inc Stock Today?

Lexicon Pharmaceuticals Inc (LXRX) stock is trading at $2.19 as of 12:43 PM on Monday, Mar 25, a loss of -$0.07, or -3.1% from the previous closing price of $2.26. The stock has traded between $2.17 and $2.36 so far today. Volume today is below average. So far 1,540,292 shares have traded compared to average volume of 5,973,737 shares. Click Here to get the full Stock Report for Lexicon Pharmaceuticals Inc stock.